Categories
    REAL TIME VIDEOS
    Newsletter
* Email
Name 
Subscribe
 
    News
CelprogenDe-DifferentiatesHuman Induced Pluripotent Cells (iPCs) Into Germ Progenitor Cells
April 6, 2010

Celprogen Launches Human Triple Negative Breast Cancer Stem Cells
August 3, 2009

Celprogen Introduces Non-Viral Method to Reprogram Adult Somatic Cells (Dedifferentiation) to Their Embryonic Pluripotent Cells (iPCs)
  January 12, 2009

Read More...

img1 img2 img3 img4 img5 img6 img7

Celprogen Inc.

WELCOME TO CELPROGEN

CELPROGEN is a biotechnology company developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media including ECM’s, are manufactured and produced in the United States of America.

CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, Invitro diagnostics and academic partnership for drug discovery.

 

 

    DIVISIONS
THERAPEUTICS
Has focused its Drug Discovery efforts in the development of Pharmaceutical agents and Drugs in the following categories: Cardiovascular, Diabetes, Neurological, Renal and Metabolic disorders.

LIFE SCIENCE
Provides research tools & solutions for assays, enzymes, antibodies, antigens, stem cells, Tissue culture expansion and differentiation media, primary and established cell cultures, tumor markers, cardiac markers, proteomic and genomic reagents and assay systems for life science academic and pharmaceutical communities.

DEVICE
Provides novel ELISA based assay, protein array, DNA array and cellular based assay systems that are cost effective for Research and Invitro diagnostics Indutstries.

 

orange county web design by b3net.com